Glancy Prongay Wolke & Rotter LLP reminds Embecta Corp. shareholders of the August 17, 2026 deadline to file a lead plaintiff motion in a securities fraud class action. The lawsuit covers investors who purchased Embecta common stock between November 25, 2025 and May 4, 2026. The complaint alleges the company made misleading statements and failed to disclose that its guidance was unattainable and that weakness in the U.S. pen needle market would disrupt revenue. On May 5, 2026, Embecta reported a revenue decline of over 14% and lowered its fiscal 2026 guidance, causing its stock to drop 57.8% to $3.90 per share.
Embecta CorpSecurities fraud lawsuit alleging misleading statements about guidance and revenue, causing 57.8% stock drop.